5Mandal S, Garg S, Venkatesh P, et al. Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization. Arch Ophthalmol, 2007,125 : 1487-1492.
6Gomi F, Nishida K, Oshima Y, et al. Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone. Am J Ophthalmol, 2007, 143:507-510.
7Chan WM, Lai TY, Liu DT, et al. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol, 2007, 143:977-983.
8Postelmans L, Pasteels B, Coquelet P. et al. Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol, 2004,138 : 803-880.
9Ferrar N. Vascular endothelial growth factor:basic science and clinical progress[J]. Endocrine Rev,2004,25: 581-611.
10Adamis AP, Shima DT, ToJentJno MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in nonhuman primate[J]. Arch Ophthamol, 1996,114 : 66-71.
